Results 191 to 200 of about 101,002 (279)

Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience [PDF]

, 2012
Brian Shrager, Ghalib Jibara, Parissa Tabrizian, Sasan Roayaie, Stephen C. Ward   +4 more
openalex   +1 more source

Association of histologic disease activity with progression of nonalcoholic fatty liver disease [PDF]

, 2019
Brundt, Elizabeth M, et al,, Kleiner, David E   +2 more
core   +1 more source

Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis

Cell Proliferation, Volume 59, Issue 2, February 2026.
Mitochondrial quality control (MQC) impairment plays a central role in driving the pathogenesis of metabolism‐associated steatotic liver disease (MASLD). Specifically, this is manifested as reduced mitophagy; increased mitochondrial fission and decreased fusion; and impaired mitochondrial biogenesis.
Wenkai Fu, Junqi Wang, Nan Lu, Zhijiang Guo, Sang‐Bing Ong, Yong Gao, Hao Zhou, Xing Chang, Miao Meng   +8 more
wiley   +1 more source

Beyond the Green Light: Evaluating the Uncertainties of Resmetirom for Non-Cirrhotic Nonalcoholic Steatohepatitis Treatment. [PDF]

Health Sci Rep
Sajid HMM, Rahman F, Mahmoud A.
europepmc   +1 more source

Evaluation of Pathogenic Variants Associated With Monogenic Disorders of Dyslipidemia in Patients With Well Characterised MASLD

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background and Aims Dyslipidemia is common in patients with MASLD, but the frequency and significance of inherited disorders of dyslipidemia are unclear. We investigated the prevalence and significance of pathogenic variants associated with selected monogenic disorders of dyslipidemia in 3358 patients with well‐characterised MASLD. Approach We
Tae‐Hwi Schwantes‐An, Marco A. Abreu, Brent A. Neuschwander‐Tetri, Jian Wang, Xiuqing Guo, Jingyi Tan, Robert A. Hegele, Nicholas O. Davidson, Luca Lotta, Niek Verweij, Katherine P. Yates, Jerome I. Rotter, Naga Chalasani   +12 more
wiley   +1 more source

The Construction and Performance Evaluation of a Risk Prediction Model for Nonalcoholic Steatohepatitis Based on Serological Markers. [PDF]

Gastroenterol Res Pract
Huang D, Zhang W, Fang Y, Liu T, Zhou D.
europepmc   +1 more source

High Healthcare Cost Burden for Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC) Progression within Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH) Patients in Japan: a Real-world Data Study Using a Claims Database

, 2021
Ken Hasegawa, Atsushi Aruga
openalex   +2 more sources

Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background and Aims There is limited real‐world data on the prognosis of patients with cirrhosis due to metabolic dysfunction‐associated steatotic liver disease (MASLD). We sought to describe the characteristics and assess the clinical course of MASLD‐cirrhosis.
Ying Shang, Linnea Widman, Xiao Zhang, Gail Fernandes, Matthew G. Melaragno, Samuel S. Engel, Johan Vessby, Mattias Ekstedt, Hannes Hagström   +8 more
wiley   +1 more source

Shugan Xiaozhi Decoction attenuates nonalcoholic steatohepatitis by modulating oxidative stress and AMPK pathway. [PDF]

BMC Complement Med Ther
Yang R, Feng L, Gong Z, Yang H, Du H, Chen J, Qin M, Chen N, Huang H, Wang P, Wu Q, Xing Y.   +11 more
europepmc   +1 more source

Multiparametric Quantitative Ultrasound as a Potential Imaging Biomarker for Noninvasive Detection of Nonalcoholic Steatohepatitis: A Clinical Feasibility Study. [PDF]

Diagnostics (Basel)
Chattopadhyay T, Chan HJ, Le DC, Wang CY, Tai DI, Zhou Z, Tsui PH.   +6 more
europepmc   +1 more source